Johnson & Johnson agreed to acquire Intra-Cellular Therapies Inc, a company focused on treatments for central nervous system disorders, for about $14.6 billion. J&J will pay $132 a share, the company said in a...
Pharmaceutical
GSK to buy US biotech firm IDRx for up to $1.15 billion
British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a rare type of tumour. IDRx, a privately held biotechnology...
J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports
Drug maker Johnson & Johnson is exploring a bid to acquire Intra-Cellular Therapies, a biopharmaceutical company, Bloomberg News reported on Sunday, citing people familiar with the matter. Intra-Cellular has a...
Asset management firm DBAY to buy UK’s Alliance Pharma in $430 million deal
Britain’s Alliance Pharma said on Friday it has agreed to be acquired by asset management firm DBAY Advisors in an all-cash deal valuing the healthcare group at 349.7 million pounds ($429.6 million). The 62.5...
Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida
Roche on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics, a specialist in complex immune cell therapies to treat several types of blood cancer. Roche said it has...
Alkem Laboratories to sell Pithampur unit for Rs 149 crore
Alkem Laboratories Ltd on Tuesday said it will sell its manufacturing facility in Pithampur, Madhya Pradesh, to Rubicon Research Ltd for Rs 149 crore, on a slump sale basis. The company has entered into a business...
Sun Pharma shares in spotlight as company to sell 100% stake in Japanese arm
Sun Pharmaceutical Industries’ share price will remain in focus on Wednesday after the company announced its plan to sell its entire holding in its Japanese subsidiary. In an exchange filing, Sun Pharma stated...
Lupin acquires ‘Huminsulin’ in India from Eli Lilly and Co
Pharma major Lupin Ltd on Monday said it has acquired the anti-diabetic medicine ‘Huminsulin’ in India from Eli Lilly and Company for an undisclosed sum to further enhance its diabetes portfolio. Lupin has...
Quadria Capital to pick up minority stake in drug company Aragen
Quadria Capital, Singapore-headquartered Asia focused healthcare private equity firm, will pick up a minority stake in Hyderabad-based contract research development and manufacturing organisation (CRDMO) Aragen Life...
Sun Pharma Advanced Research Company to acquire 55% stake in Tiller Therapeutics
Sun Pharma Advanced Research Company announced the signing of a binding Letter of Intent (LOI) with the University of California, San Francisco (UCSF), through the office of OTMA, and Tiller Therapeutics Inc. (Tiller)...
Suven Pharma to acquire 56 pc stake in US-based firm for USD 64.4 mn
Suven Pharmaceuticals on Saturday said it will acquire a controlling stake in US-based NJ Bio Inc for USD 64.4 million. The company will buy a 56 per cent stake in Princeton, NJ Bio, Suven Pharmaceuticals said in a...
Novo Holdings’ $16.5 bln Catalent buy wins EU antitrust approval
Novo Holdings on Friday gained unconditional EU antitrust approval for its $16.5 bln acquisition of U.S. contract drug maker Catalent after EU regulators said they did not see any competition issues. Novo Holdings, the...
